Company name: Peloton Pharmaceuticals
Description: Producer of cannabis intended to be used for medical application. The company’s cannabis will be produced in a 40,000 square foot cannabis production facility in Pointe Claire, Quebec, enabling patients to get pharmaceutical grade cannabis.
Year founded: 2013
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
Start up capital raised (USD Million):
Business status: Bankruptcy: Admin/Reorg
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: The company was acquired by Aurora Cannabis (TSXV: ACB) for CAD 7 million in April 4, 2017. The Peloton acquisition is another major strategic advance for Aurora, expected to provide them in the near term with additional high quality, low-cost production capacity, as well as an important presence in Montreal, with the capability to serve Québec and the Atlantic Provinces and to further expand their industry-leading e-commerce strategy.
Number of active investors:
Profile last updated: 08-Sep-2018
Last known valuation: 5.22
Last known valuation date: 04-Apr-2017